[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100535079":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":35,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"University Hospital, Essen","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"RADIATION","PET based Raditherapy boost","An Interim PET CT will be performed. If there is residual vital tumor, a higher radiation dose will be applied.",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Maja Guberina","CONTACT","020172383121","maja.guberina@uk-essen.de",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":7,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"University Hospital Essen","RECRUITING","Essen","Germany","DE",{"type":27,"coordinates":28},"Point",[29,30],7.01228,51.45657,{"lat":30,"lon":29},[33],{"name":15,"role":16,"phone":34,"phoneExt":7,"email":18},"+4920127232321",{"type":36,"investigatorFullName":15,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","PD Dr. med. (MD) Maja Guberina, specialist in radiation oncology, senior consultant","100535079","pet-guided-radiotherapy-for-patients-with-small-cell-lung-cancer-100535079",false,"NCT06247163","PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.","Prospective PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.","PET-ART","Inclusion Criteria:\n\n* Histopathologic confirmation\n* Limited disease\n\nExclusion Criteria:\n\n* Other histology than small cell lung cancer\n* Further tumor diagnosis\n* ECOG 3 or worse\n* Extensive disease\n* stage IV","ALL","18 Years",{"count":49,"type":50},30,"ESTIMATED","OBSERVATIONAL","There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society\u002FCancer Aid\u002FAWMF",[54],"Small Cell Lung Carcinoma","2024-09-25",{"date":57,"type":58},"2024-09-27","ACTUAL",{"date":60,"type":58},"2024-02-22",{"date":62,"type":50},"2029-06-22",{"name":5,"class":6},1]